Results indicated that TD decreased the bone quality and changed gene expression of tibial growth plates (COL1A1, COL5A1, and COL8A1) and blood (EPSTI1, USP41, and SLC5A7), which could help uncover the underlying mechanisms and identify practical molecular markers for TD. This evidence concerns the gene EPSTI1 and thanatophoric dysplasia.